PMV Pharmaceuticals, Inc.
NASDAQ:PMVP
Overview | Financials
Company Name | PMV Pharmaceuticals, Inc. |
Symbol | PMVP |
Currency | USD |
Price | 1.55 |
Market Cap | 80,208,005 |
Dividend Yield | 0% |
52-week-range | 1.4 - 2.82 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. David H. Mack Ph.D. |
Website | https://www.pmvpharma.com |
An error occurred while fetching data.
About PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD